Canine lymphoma drug receives conditional approval from FDA

The FDA has conditionally approved Tanovea-CA1, an injected form of rabacfosadine, for treatment of canine lymphoma when prescribed and administered by a licensed veterinarian. The drug is infused in diluted form over 30 minutes, and the active ingredient targets rapidly proliferating malignant cells.WTAJ-TV (Altoona, Pa.) (1/3)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s